Home › Asset managers › Compare 2024-2025 › John Hancock vs Brighthouse

John Hancock vs Brighthouse: how alike they voted, 2024-2025

96.3% When both took a single position, they voted the same way on 96.3% of 13,754 items (13,248 the same, 506 different). 5,414 items where at least one of them split its funds are listed separately below. Both voted on 19,168 items in all.

Note on Brighthouse: its funds did not all vote the same way on 14.7% of the 97,681 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.

John Hancock 2024-2025 · Brighthouse 2024-2025 · Download the item list (CSV)

By who put the item on the ballot. “Same position” = Same / (Same + Differ); split items are not in it. “Fund-level” is a second view over all common items: the chance that a fund of each manager, picked at random, voted the same way, which gives partial credit where a manager split.
	Common items	Same	Differ	Split (not in %)	Same position	Fund-level
All ballot items	19,168	13,248	506	5,414	96.3%	87.4%
Board proposals	15,763	10,766	467	4,530	95.8%	87.5%
E&S shareholder proposals	255	2	3	250	40.0%	39.8%
Other items	3,150	2,480	36	634	98.6%	90.8%

Where they did not vote alike

Everything Voted differently Split votes

All ballot items Board proposals E&S shareholder proposals Other items

506 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.

Company	Meeting	Proposal	On the ballot from	Board recommended	John Hancock	Brighthouse
YELLOW PAGES LTD	May 14, 2025	ELECTION OF DIRECTOR: TREENA COOPER Director Elections	Board	Not determined	ABSTAIN 2 funds	WITHHOLD 1 fund
ZALANDO SE	May 27, 2025	ELECT SURBHI MARWAH, KLAUS MOLLER-ARENTOFT AND ANDREA RICCIARELLI TO THE SUPERVISORY BOARD AS SUBSTITUTES TO EMPLOYEE REPRESENTATIVES Director Elections	Board	For	FOR 5 funds	AGAINST 1 fund
ZENTALIS PHARMACEUTICALS INC.	June 17, 2025	To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay	Board	For	AGAINST 5 funds	ABSTAIN 1 fund
ZENTALIS PHARMACEUTICALS INC.	June 17, 2025	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related	Board	For	FOR 3 funds	ABSTAIN 1 fund
ZIONS BANCORPORATION	May 2, 2025	Approval, on a nonbinding advisory basis, of the compensation paid to the Bank's named executive officers with respect to fiscal year ended Dec. 31, 2024. Say-on-Pay	Board	For	FOR 10 funds	ABSTAIN 2 funds
ZIONS BANCORPORATION	May 2, 2025	Ratification of the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm to audit the Bank's financial statements for the current year. Audit-related	Board	For	FOR 10 funds	ABSTAIN 2 funds

← All 20 managers, 2024-2025

How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.